Wolverine Asset Management’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-40,300
| Closed | -$3.42M | – | 1862 |
|
|
2019
Q4 | $3.42M | Hold |
40,300
| – | – | 0.04% | 326 |
|
|
2019
Q3 | $2.02M | Buy |
40,300
+14,800
| +58% | +$590K | 0.03% | 424 |
|
|
2019
Q2 | $929K | Buy |
25,500
+8,500
| +50% | +$277K | 0.01% | 689 |
|
|
2019
Q1 | $475K | Sell |
17,000
-17,500
| -51% | -$412K | 0.01% | 864 |
|
|
2018
Q4 | $660K | Buy |
34,500
+17,000
| +97% | +$395K | 0.01% | 958 |
|
|
2018
Q3 | $523K | Buy |
17,500
+16,500
| +1,650% | +$622K | 0.01% | 1006 |
|
|
2018
Q2 | $36K | Hold |
1,000
| – | – | ﹤0.01% | 1274 |
|
|
2018
Q1 | $32K | Buy |
+1,000
| New | +$31.2K | ﹤0.01% | 1320 |
|
|
2017
Q3 | – | Sell |
-4,900
| Closed | -$186K | – | 1556 |
|
|
2017
Q2 | $186K | Buy |
4,900
+2,900
| +145% | +$129K | ﹤0.01% | 956 |
|
|
2017
Q1 | $97K | Buy |
2,000
+800
| +67% | +$36.5K | ﹤0.01% | 951 |
|
|
2016
Q4 | $40K | Hold |
1,200
| – | – | ﹤0.01% | 1029 |
|
|
2016
Q3 | $45K | Buy |
+1,200
| New | +$45.2K | ﹤0.01% | 1063 |
|
|
2013
Q3 | – | Sell |
-524
| Closed | -$17K | – | 2936 |
|
|
2013
Q2 | $17K | Buy |
+524
| New | +$17.5K | ﹤0.01% | 2077 |
|
Other funds holding MDCO
Wolverine Asset Management's MDCO Position: Q1 2019 in Review
Wolverine Asset Management sold out of Medicines Co (MDCO) in Q1 2019, closing a stake of 3,513 shares — an estimated $82.8K sold.
Wolverine Asset Management first reported a position in MDCO in Q4 2018 and held it in 1 quarter. The position peaked at $67K in Q4 2018. 203 funds tracked by Wall St. Rank hold MDCO as of Q1 2019.
- Wolverine Asset Management reported no remaining Medicines Co position as of Q1 2019 after selling out during the quarter.
- Wolverine Asset Management sold 3,513 Medicines Co shares in Q1 2019, an estimated $82.8K.
- Wolverine Asset Management first reported a position in Medicines Co in Q4 2018 and held it in 1 quarter.
- Wolverine Asset Management's Medicines Co position peaked at $67K in Q4 2018.
- 203 funds tracked by Wall St. Rank held Medicines Co as of Q1 2019.
Based on Wolverine Asset Management's 13F filing for Q1 2019, filed 15 May 2019.